Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsuya

Showing results (251-260 of 343) with videos related to

Pageof 35
Sort By:
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 1, 1984
[Statistical study on tumors of the urinary bladder--clinical and pathological aspects of 228 cases]M Takashi, T Murase, T Sobajima, et al.
Lancet (London, England)|March 24, 1984
Immune T cells reactive against human T-cell leukaemia/lymphoma virusH Mitsuya, L A Matis, M Megson, et al.
Journal of Medicinal Chemistry|March 31, 1995
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosineH Ford, M A Siddiqui, J S Driscoll, et al.
Biochemical and Biophysical Research Communications|March 13, 1987
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analoguesS Narumiya, M Hirata, T Nanba, et al.
Haematology and Blood Transfusion|January 1, 1987
Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAVL Ratner, A Fisher, L L Jagodzinski, et al.
Antiviral Chemistry & Chemotherapy|May 21, 1999
Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivativeM Okamoto, M Fujiwara, E Kodama, et al.
Leukemia|November 21, 1998
Expression of Bcl-2 family of proteins in fresh myeloma cellsN Harada, H Hata, M Yoshida, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphologyR W Humphrey, A Ohagen, D A Davis, et al.
The Journal of Infectious Diseases|May 1, 1995
Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infectionB Y Nguyen, R Yarchoan, K M Wyvill, et al.
Oncogene|September 15, 2009
PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAILS Ueno, H Tatetsu, H Hata, et al.
Pageof 35

Showing results (251-260 of 343) with videos related to

Sort By:
Pageof 35
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 1, 1984
[Statistical study on tumors of the urinary bladder--clinical and pathological aspects of 228 cases]M Takashi, T Murase, T Sobajima, et al.
Lancet (London, England)|March 24, 1984
Immune T cells reactive against human T-cell leukaemia/lymphoma virusH Mitsuya, L A Matis, M Megson, et al.
Journal of Medicinal Chemistry|March 31, 1995
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosineH Ford, M A Siddiqui, J S Driscoll, et al.
Biochemical and Biophysical Research Communications|March 13, 1987
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analoguesS Narumiya, M Hirata, T Nanba, et al.
Haematology and Blood Transfusion|January 1, 1987
Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAVL Ratner, A Fisher, L L Jagodzinski, et al.
Antiviral Chemistry & Chemotherapy|May 21, 1999
Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivativeM Okamoto, M Fujiwara, E Kodama, et al.
Leukemia|November 21, 1998
Expression of Bcl-2 family of proteins in fresh myeloma cellsN Harada, H Hata, M Yoshida, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphologyR W Humphrey, A Ohagen, D A Davis, et al.
The Journal of Infectious Diseases|May 1, 1995
Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infectionB Y Nguyen, R Yarchoan, K M Wyvill, et al.
Oncogene|September 15, 2009
PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAILS Ueno, H Tatetsu, H Hata, et al.
Pageof 35